1. GDI2 is a novel diagnostic and prognostic biomarker in hepatocellular carcinoma
   Wen Zhang et al, 2021, Aging CrossRef
2. Disclosing Potential Key Genes, Therapeutic Targets and Agents for Non-Small Cell Lung Cancer: Evidence from Integrative Bioinformatics Analysis
   Md. Parvez Mosharaf et al, 2022, Vaccines CrossRef
3. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis
   Junwei Liu et al, 2021, BioMed Research International CrossRef
4. The Molecular Basis of Ubiquitin-Conjugating Enzymes (E2s) as a Potential Target for Cancer Therapy
   Xiaodi Du et al, 2021, International Journal of Molecular Sciences CrossRef
5. Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma
   Xia Chen et al, 2020, BioMed Research International CrossRef
6. A Five-Gene-Based Prognostic Signature for Hepatocellular Carcinoma
   Dazhi Tian et al, 2021, Frontiers in Medicine CrossRef
7. Fibrinogen-Like Protein 1 Modulates Sorafenib Resistance in Human Hepatocellular Carcinoma Cells
   Yeonghoon Son et al, 2021, International Journal of Molecular Sciences CrossRef
8. Machine Learning Screens Potential Drugs Targeting a Prognostic Gene Signature Associated With Proliferation in Hepatocellular Carcinoma
   Jun Liu et al, 2022, Frontiers in Genetics CrossRef
9. Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis
   Ainhoa Lapitz et al, 2020, Cells CrossRef
10. Identification of the Potential Prognosis Biomarkers in Hepatocellular Carcinoma: An Analysis Based on WGCNA and PPI
    Junting Huang et al, 2021, International Journal of General Medicine CrossRef